Skip to content

Bilateral Ultrasound-Guided Erector Spinae Plane Block For Postoperative Analgesia in Breast Reduction Surgery

Bilateral Ultrasound-Guided Erector Spinae Plane Block For Postoperative Analgesia in Breast Reduction Surgery: A Prospective, Randomized and Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03621345
Enrollment
60
Registered
2018-08-08
Start date
2018-08-15
Completion date
2021-09-01
Last updated
2023-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Hypertrophy, Postoperative Pain

Brief summary

Erector spinae plane (ESP) block is a novel block developed by Forero to treat severe neuropathic pain and was firstly reported in 2016. Anatomical and radiological investigations in fresh cadavers indicate that its site of action is likely at the dorsal and ventral rami of the thoracic spinal nerves. The ESP block has a clear and simple sonoanatomy, it is easy to perform, not time consuming and generally well tolerated by the patients. So, the investigators believed that the ESP block may be an effective and safer alternative to paravertebral block, epidural analgesia and other myofascial thoracic wall blocks in breast surgery and designed a prospective, randomised, placebo-controlled trial for pain management.

Interventions

PROCEDUREErector spinae plane block

Ultrasound guided bilateral erector spinae plane block will be administered. An intravenous patient control analgesia device with morphine will be given to patients.

OTHERsham block

A sham block will be applied. Skin will be infiltrated with local anesthetics, and 2 mL subcutaneous saline injection will be applied.An intravenous patient control analgesia device with morphine will be given to patients.

Sponsors

Cukurova University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists (ASA) I-II, 18-65 years of age, adult, female patients undergoing elective breast reduction surgery

Exclusion criteria

* Coagulopathy * Allergy to amide-type local anesthetics * Infection at the ESP block injection site * Severe obesity (BMI \> 35 kg/m2) * Liver or renal deficiency * Patients with anatomical deformities * Recent use of analgesic drugs * Patient refusal or inability to consent

Design outcomes

Primary

MeasureTime frameDescription
Postoperative morphine consumption24 hoursMorphine consumption in Patient Controlled Analgesia device

Secondary

MeasureTime frameDescription
Extubation and recovery timeThrough surgical operation completionUsing modified aldrete score
Pain assessed by NRS24 hoursNumeric rating scale (NRS) at rest and in motion will be recorded at intervals. NRS is a unidimensional measure of pain intensity in adults. The NRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. no pain) to '10' representing the other pain extreme (e.g. pain as bad as you can imagine or worst pain imaginable).
Degree of sedation24 hoursRamsay Sedation Scale (RSS) will be used to assess degree of sedation. The RSS was designed as a test of arousability. The RSS scores sedation at six different levels, according to how arousable the patient is. The RSS defines the conscious state from a level 1: the patient is anxious, agitated or restless, through the continuum of sedation to a level 6: the patient is completely unresponsive.
Rate of opioid related side effects24 hoursOpioid related side effects such as nause/vomiting, pruritis, bradycardia, hypotension will be evaluated at intervals up to 24 hours.
Intraoperative anesthetic consumptionDuring operation timeIntraoperative total doses of remifentanil, pentothal, desflurane consumption
Patient satisfaction assessmentAt the postoperative 24th hourIt will be assessed with patient satisfaction scale classified as 'excellent': no pain, NRS=0; 'good': very mild pain, NRS=1-2; 'moderate': mild pain, NRS=3-4.
Bilateral shoulder mobilityPreoperative and postoperative 4th, 8th, 12th, and 24th hoursIt will be assessed with ability of shoulder abduction degree
Length of stay in hospitalUntil discharge from hospital, up to 7 days postoperativelyDuration of length of stay in hospital will be recorded
Rate of block related complicationsUntil discharge from hospital, up to 7 days postoperativelyRate of block related complications such as hematoma, nerve deficit, pneumothorax etc. will be recoded.
Supplemental and rescue analgesic requirement24 hoursTotal supplemental and rescue analgesic consumption

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026